tiprankstipranks
3 Best Stocks to Buy Now, 9/11/2024, According to Top Analysts 
Market News

3 Best Stocks to Buy Now, 9/11/2024, According to Top Analysts 

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.

Pick the best stocks and maximize your portfolio:

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. 

Insmed (INSM) – This biopharmaceutical company develops therapies for diseases, particularly in the areas of lung disease and oncology. Today, Barclays analyst Leon Wang assigned a Buy rating on the stock with a price target of $90. In the last three months, all 12 Top Analysts covering the stock have rated it a Buy. Altogether, their 12-month price targets imply an upside of about 22%.

Stoke Therapeutics (STOK) – This biotechnology company develops RNA-based therapies to treat genetic diseases caused by protein deficiencies. Today, H.C. Wainwright analyst Andrew Fein maintained a Buy rating on the stock with a price target of $35. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 48%.

Roivant Sciences (ROIV) – Roivant is a commercial-stage biopharmaceutical company. Today, H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on the stock with a price target of $15. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of over 42%.

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure 

Related Articles
TheFlyInsmed price target raised to $83 from $74 at JPMorgan
TipRanks Auto-Generated NewsdeskInsmed’s Q3 2024: Strong Growth and Strategic Advances
TheFlyInsmed reports Q3 EPS ($1.27), consensus ($1.22)
Go Ad-Free with Our App